from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3795/embB

LFCtreatmentdescriptionclass of inhibitor

-0.264

Amikacinug/mL Amikacintranslation

-1.226

Cap5-10ug/mL Capreomycintranslation

-1.537

Rox10-50 ug/mL Roxithromycintranslation

0.345

SM2-5 ug/mL Streptomycintranslation

-1.087

Tet5-10 ug/mL Tetracyclinetranslation

0.457

Rif0.2-5ug/mL Rifampicintranscription

0.619

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.764

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-3.096

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.227

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.961

Clofazimine10-13 ug/mL Clofaziminerespiration

0.259

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-3.067

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.674

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.145

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.077

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.063

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.038

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.836

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.445

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-2.544

KCN5-20 ug/mL Potassium cyaniderespiration

-0.164

NaN30.2-2 mM Sodium aziderespiration

0.131

Nigericin50 uM Nigericinrespiration

-0.338

TRC10-150 ug/mL Triclosanrespiration

-1.149

TRZ10-25 ug/mL Thioridazinerespiration

-1.455

Valinomycin0.5-10 uM Valinomycinrespiration

0.805

ZnSO42 mM ZnSO4respiration

0.017

menadione6-10 ug/mL Menadionerespiration

0.241

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.758

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.110

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.534

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.464

NRP_1Non-replicating persistence stage 1dosRassociated

0.613

Amp0.2mg/mL AmpicillincellWall

0.507

Cephalexin20-100 ug/mL CephalexincellWall

0.619

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.034

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.064

EMB10-20 ug/mL EthambutolcellWall

0.355

Eta12-40 ug/mL EthionamidecellWall

0.524

INH0.2-0.4 ug/mL IsoniazidcellWall

0.517

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.297

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.661

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.490

BZA0.12 mg/mL BenzamidearomaticAmides

0.533

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.733

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.502

H2O24 mM hydrogen peroxideDNAdamaging

0.188

Levo10 ug/mL LevofloxacinDNAdamaging

0.570

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.678

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.435

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.453

UVUV-irradiationDNAdamaging

-0.321

ARP41-4 ug/mL Antitubercular compound ARP4?

0.874

Antimycin12.5-50 ug/mL Antimycin A?

0.685

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.501

PA_110-50 ug/mL Antitubercular compound PA-1?

0.626

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.838

PA8240.2-2 ug/mL PA-824?

-1.370

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.043

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.079

Verapamil50 uM Verapamil?

0.163

mercaptoethanol2 mM 2-Mercaptoethanol?

0.994

methoxatin10-20 ug/mL Methoxatin?